Publications
The Sydney Blood Cancer Research publishes journal articles, conference papers, book chapters, working or technical papers. This service allows members to share their research with the wider community.
Index of Publications
Publications 2024
Publications 2023
Publications 2022
Publications 2021
Recent Publications
2020
A Phase 3 Trial of Luspatercept in Patients With Transfusion-Dependent β-Thalassemia.
Cappellini MD, Viprakasit V, Taher AT, Georgiev P, Kuo KHM, Coates T, Voskaridou E, Liew HK, Pazgal-Kobrowski I, Forni GL, Perrotta S, Khelif A, Lal A, Kattamis A, Vlachaki E, Origa R, Aydinok Y, Bejaoui M, Ho PJ et al. (2020)
New England Journal of Medicine 382 (13), 1219-1231
2020
Successful kidney transplantation in a patient with stable multiple myeloma.
Lai C, Ying T, Ho PJ, Wyburn K, Gallagher M, Chadban S (2020)
Intern Med J. 50(4):492-494. doi: 10.1111/imj.14790.
2020
Patient-reported outcome measures in multiple myeloma: Real-time reporting to improve care (My-PROMPT) - a pilot randomized controlled trial.
Moore EM, King TA, Wood EM, Ruseckaite R, Klarica D, Spencer A, Ho PJ, Quach H, Prince HM, McQuilten ZK.
Am J Hematol (2020) 95:E178-181. doi: 10.1002/ajh.25815.
2019
MASS CYTOMETRY DISCOVERS TWO DISCRETE SUBSETS OF CD39-TREG WHICH DISCRIMINATE MGUS FROM MULTIPLE MYELOMA.
Marsh-Wakefield F, Kruzins A, McGuire HM, Yang S, Bryant C, Fazekas de St Groth B, Nassif N, Byrne SN, Gibson J, Brown C, Larsen S, McCulloch D, Boyle R, Clark G, Joshua D, Ho PJ,Vuckovic S.
Front Immunol. 2019 Aug 2;10:1596. doi: 10.3389/fimmu.2019.01596.
2019
CD300F EPITOPES ARE SPECIFIC TARGETS FOR ACUTE MYELOID LEUKEMIA WITH MONOCYTIC DIFFERENTIATION.
Abadir E, Gasiorowski RE, Lai K, Kupresanin F, Romano A, Silveira PA, Lo TH, Fromm PD, Kennerson ML, Iland HJ, Ho PJ.
Molecular oncology. 2019 Jul 23.
2019
CHEMOTHERAPY FOLLOWED BY ANTI-CD137 MAB IMMUNOTHERAPY IMPROVES DISEASE CONTROL IN A MOUSE MYELOMA MODEL
Guillerey C, Nakamura K, Pichler AC, Barkauskas D, Krumeich S, Stannard K, Miles K, Harjunpää H, Yu Y, Casey M, Doban AI, Lazar M, Hartel G, Smith D, Vuckovic S, Teng MW, Bergsagel PL, Chesi M, Hill GR, Martinet L, Smyth MJ.
JCI Insight. 2019 Jun 13;5. pii: 125932. doi: 10.1172/jci.insight.125932
2019
EXAMINATION OF CD302 AS A POTENTIAL THERAPEUTIC TARGET FOR ACUTE MYELOID LEUKEMIA.
Lo TH, Abadir E, Gasiorowski RE, Kabani K, Ramesh M, Orellana D, Fromm PD, Kupresanin F, Newman E, Cunningham I, Hart DN. PloS one.
2019 May 10;14(5):e0216368